What should you ask about naltrexone dosing for alcohol use disorder?
This article describes medications used for alcohol use disorder. It is educational and not medical advice. Talk to a licensed clinician about whether any specific medication fits your situation.
You went looking for a number, and the honest answer is that the number is the least useful part — what's worth carrying out of this page is what actually decides naltrexone dosing, and what to ask the person who decides it.
Maybe a friend mentioned naltrexone, or you read somewhere that there's a pill that can make drinking feel less rewarding, and the natural next question was the practical one: okay, how much? Here's the short answer. Dosing is a prescribing decision, worked out between you and a clinician after a handful of specific safety questions get answered. Knowing what those questions are puts you in a far stronger position than any number copied from an article ever could.
Why won't an article just give you the number?
Because the dose is the last step in a chain of decisions, and every earlier link in that chain is personal. Start with what the medication actually is. Naltrexone is FDA-approved for treating alcohol dependence, and it works on the brain's opioid receptors — the same receptors that help produce the warm, rewarding lift a drink can give. Blocking them mutes that lift, which is why the American Academy of Family Physicians describes opioid blockers like naltrexone as a useful add-on to counseling and other support: drinking simply feels less worth reaching for. SAMHSA's plain-language summary puts the practical effect in one line — it reduces cravings and the amount people drink.
Notice what's already true before any number enters the picture: this is a medication that changes how drinking feels, prescribed inside a plan. The FDA label itself says naltrexone hasn't been shown to help except as part of a broader program for addressing the drinking — it's one working part, not the whole machine. A clinician who takes that seriously will spend most of the first conversation on you, not on arithmetic.
What the dosing conversation actually depends on
Mostly five things, and you can think through every one of them before the appointment.
- Opioids, before anything else. This is the hard gate. Per the FDA label, naltrexone must not be used by people taking opioid pain medications, people currently dependent on opioids, or people in opioid withdrawal — it blocks those medicines from working and can set off sudden, severe withdrawal. Expect to be asked about this first, including prescriptions you might not think of as opioids.
- The form it takes. Naltrexone comes as a daily tablet and as a longer-acting injection given at a clinic. Those are different routines with different follow-up, and the choice between them shapes everything downstream.
- Your liver. Naltrexone is processed by the liver, and heavy drinking is hard on the liver, so many clinicians order blood tests before starting and check again along the way. That's routine caution, not a red flag about you.
- Your goal. Cutting back and stopping entirely are both legitimate goals, and they lead to different plans. Say which one you actually want, not the one you think sounds better.
- The rest of your health picture. Other medications, pregnancy or breastfeeding, kidney problems, mental health — the ordinary prescribing questions, all of which can move the plan.
None of this requires you to tell your story perfectly. Plain facts — how many drinking days in a typical week, what a heavier day looks like, what has happened when you've stopped before — do more work than a polished confession.
Bring these questions with you
A short list is enough. The point is to make the clinician's answer concrete instead of general.
- Fit: "Given my drinking pattern and my goal, is naltrexone the right option to discuss first — and if not, what is?"
- Safety: "Is there anything in my history — opioid prescriptions, liver results, other medications — that rules this out or needs checking before we start?"
- The plan around it: "What support goes alongside the medication, and how will we judge whether it's working for me?"
- Follow-up: "How often will we check in, which side effects should I report right away, and what's the next step if this doesn't fit?"
On that last one, it helps to know the common side effects going in — nausea, headache, dizziness, and fatigue are the usual ones, typically early on — so you can tell an ordinary adjustment period from something worth a prompt call. If a clinician answers those four questions, you'll leave with an actual plan — including, yes, a dose — instead of a prescription floating free of context.
Is naltrexone the only medication worth asking about?
No, and it's fair to want the comparison before you're sitting in an appointment. Naltrexone is one of three FDA-approved medications for alcohol use disorder, and a peer-reviewed overview of the three shows they do genuinely different jobs. Disulfiram blocks your body's ability to finish breaking down alcohol, so a toxic byproduct called acetaldehyde builds up and drinking on it makes you feel ill — it works as a deterrent, a tripwire you set on purpose. Acamprosate leaves the reward of drinking alone and instead steadies the over-revved "go" signaling a brain develops after long heavy drinking, which is why it's approved for staying stopped once you've already quit. Naltrexone is the one aimed at the reward itself.
The evidence isn't identical across the three, either. An AHRQ systematic review of AUD medications in everyday clinic settings found that oral naltrexone and acamprosate each had moderate-strength evidence for helping people avoid a return to drinking, while the evidence for disulfiram against placebo was too thin to judge. That doesn't crown a winner — which one to raise first depends on whether your goal is cutting back or staying stopped, what your liver and kidneys can handle, and what happened with anything you've tried before. It just means the naltrexone-or-acamprosate question is a reasonable one to ask out loud.
Whichever medication you ask about, asking at all is rarer than it should be. In 2024, NIAAA estimates 27.9 million people ages 12 and older in the U.S. had past-year alcohol use disorder — about 9.7% of that age group — yet only about 2.1 million of them, roughly 7.6%, received any alcohol treatment that year. That gap is about access and awareness, not about the medicines failing; for most people, the conversation simply never happens.
When it's more than a dosing question
If your body pushes back when you stop drinking, safety comes before any medication decision. Naltrexone is not a withdrawal treatment, and stopping suddenly after heavy daily drinking can be dangerous on its own. If past attempts to stop have brought shaking, sweating, or a racing heart, tell the clinician that first — how to stop safely becomes the opening question, not dosing. And if stopping brings seizures, confusion, or hallucinations, that is an emergency right now: call 911 or go to an emergency room. If any of this comes tangled with thoughts of harming yourself, call or text 988 before you do anything else on this page.
For everything short of that, the step is simpler than it feels: put the questions above in front of someone licensed to answer them. If you don't have a clinician to bring that list to, Clero can connect you with a licensed clinician by telehealth to review your history and your goal and talk through whether naltrexone — or one of the alternatives — belongs in your plan.
You started with "how much." The stronger version of that question is "what would make this safe and workable for me" — and that one, a clinician can actually answer.
This article is general education, not medical advice or a dosing guide; decisions about naltrexone belong with a licensed clinician who knows your history. In a crisis, real help comes first: 988 if you're having thoughts of self-harm, 911 or an emergency room for severe withdrawal symptoms like seizures or confusion.
Want the private naltrexone update?
Join the launch list to hear first. Today, this is still educational content, not a prescription request or clinical intake.